Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Line of Credit for Government Contractors | Parabilis
Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name ...
Newsletter Signup Landing Page - Parabilis | Parabilis - A Better ...
Parabilis Medicines Updates Executive Leadership Team | Contract Pharma
Parabilis Medicines raises record $670 million in biotech IPO
Parabilis | WIPP Business Summit
Parabilis - A Better Financial Partner for Government Contractors on ...
Government Contract Financing | Parabilis
nference Establishes AI Research Partnership with Parabilis Medicines ...
Parabilis Medicines on LinkedIn: #parabilismedicines # ...
Culture - Parabilis Medicines
StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO
Parabilis Medicines Logo & Brand Assets (SVG, PNG and vector) - Brandfetch
Parabilis Medicines Unveils Progressive Findings at ASCO 2025 ...
Upcoming Events and Speaking Engagements | Parabilis
Parabilis Medicines on LinkedIn: #parabilismedicines #helicons # ...
Parabilis | The Org
Parabilis IPO Target Rises to $633M | Intent.Health
#parabilismedicines #drugdiscovery #oncology | Parabilis Medicines
Navigating the Helicon Universe: The Parabilis Discovery Platform ...
Parabilis Medicines | The Org
Parabilis to present FOG-001 data at ESMO25 | Parabilis Medicines ...
How We Got Here - Parabilis Medicines
Parabilis Medicines - Drug pipelines, Patents, Clinical trials - Synapse
Parabilis sets a record with a $670M biotech IPO | BioPharma Dive
About Parabilis
Parabilis - Win Government Contracts
Parabilis Medicines is built to develop transformative medicines ...
Presenting ERG degrader data at AACR Annual Meeting | Parabilis ...
Parabilis IPO: 7 Things to Know Before PBLS’ $475M Debut | EBC ...
Connections & Cocktails - Parabilis
#parabilismedicines #biotech #drugdiscovery #oncology | Parabilis ...
#gi25 #creatingextraordinarymedicines #colorectalcancer | Parabilis ...
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too ...
Parabilis Medicines Announces Closing of Upsized Initial Public ...
#nat8asbc2024 | Parabilis - A Better Financial Partner for Government ...
Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates ...
Funding Fundamentals: Supporting Government Contractors - Parabilis
2025 National Small Business Conference - Parabilis
Parabilis Medicines (PBLS) Stock Price & Overview
Why Helicons? - Parabilis Medicines
BIOTECH (200) Stapled Peptides: From Aileron to Parabilis Medicines ...
입문서: Parabilis Medicines(PBLS US) - 2026년 6월 - αSK
Parabilis | 2025 National HUBZone Conference
Parabilis Space Technologies looks to move testing operations to Ramona ...
PARABILIS MEDICINES AKTIEN News | A42D53 Nachrichten
#clinicaldevelopment #cancer #teamparabilis… | Parabilis Medicines
National 8(a) Association Small Business Conference Recap - Parabilis
National HUBZone Conference - Parabilis
Regeneron Signs $2.32B Parabilis Helicon Conjugate Deal | Pharma Now
Parabilis CEO Reveals How It Will Allocate $305 Million in Series F ...
#blackhistorymonth #teamparabilis #parabilismedicines | Parabilis Medicines
Lauren Zarnock - Parabilis
Who We Are - Parabilis Medicines
Parabilis Medicines - PBLS - Stock Price & News | The Motley Fool
The Parabilis team had an incredible time sponsoring #GlobalAlts2025 in ...
Parabilis IPO: 7 Hal yang Perlu Diketahui Sebelum Debut PBLS senilai ...
Awais Bhatti - Parabilis
Parabilis prices IPO at an ambitious $475 million | pharmaphorum
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor ...
Parabilis Medicines to Present Overview of Ongoing Phase 1/2 Study of ...
Parabilis Medicines (PBLS) - Market capitalization
Parabilis Medicines prices upsized IPO at $20 per share, raising $670 ...
Parabilis Medicines Announces Strategic Collaboration with Regeneron ...
Team Parabilis - Race to Cure Sarcoma Boston
Parabilis Medicines Inc IPO History, Live Price & Valuation | IPO Tracker
Kristen McGough - Parabilis
Parabilis Medicines, Inc. $305M Series C+ Funding (2026) | Investors ...
Parabilis Medicines, Regeneron Partner to Advance Novel Antibody ...
Parabilis Medicines - LifeScienceHistory.com
Parabilis Inks Deal with Regeneron, Raises $770 Million in IPO – ISPE ...
Parabilis Medicines logo in transparent PNG and vectorized SVG formats
Parabilis Medicines Reports Positive Proof-of-Mechanism Data for ...
Parabilis Medicines | F6S
I’m grateful for the opportunity I had this summer interning at ...
Daily Business Report: June 14, 2024, San Diego Metro Magazine
zolucatetide (FOG-001)
CTNNB1 - Drugs, Indications, Patents - Synapse
FogPharma rebrands as Parabilis, highlighting next drugs
Commercial Lending Software and Loan Management Platform | Cync Software
100 Top Companies in Massachusetts · July 2026 | F6S
Funding Fundamentals: How to Prepare Your Business for Federal Contract ...
Parabilis, chasing ‘undruggable’ targets, nabs $305M amid VC funding ...
EpiBiologics, Parabilis, Alveus, Novo Nordisk: Readout Newsletter
Zolucatetide Receives FDA Orphan Drug Designation for Desmoid Tumors ...
#asco25 #desmoid #colorectalcancer #asco #drugdiscovery #oncology ...
FDA grants Fast Track to FOG-001 for desmoid tumors treatment ...
Parabilis’in 670 Milyon Dolarlık Halka Arzı: Biyoteknolojide Yeni Rekor ...
SciNote ELN for Antibody therapy R&D - SciNote
#parabilismedicines #helicons #creatingextraordinarymedicines #biotech ...